153 related articles for article (PubMed ID: 8610217)
1. Primary Sjögren's syndrome (SS) and malignant lymphoma. A retrospective cohort study of 55 patients with SS.
Zufferey P; Meyer OC; Grossin M; Kahn MF
Scand J Rheumatol; 1995; 24(6):342-5. PubMed ID: 8610217
[TBL] [Abstract][Full Text] [Related]
2. Mortality in Sjögren's syndrome.
Voulgarelis M; Tzioufas AG; Moutsopoulos HM
Clin Exp Rheumatol; 2008; 26(5 Suppl 51):S66-71. PubMed ID: 19026146
[TBL] [Abstract][Full Text] [Related]
3. Prognosis and outcome of non-Hodgkin lymphoma in primary Sjögren syndrome.
Voulgarelis M; Ziakas PD; Papageorgiou A; Baimpa E; Tzioufas AG; Moutsopoulos HM
Medicine (Baltimore); 2012 Jan; 91(1):1-9. PubMed ID: 22198497
[TBL] [Abstract][Full Text] [Related]
4. Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients.
Papageorgiou A; Ziogas DC; Mavragani CP; Zintzaras E; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
PLoS One; 2015; 10(2):e0116189. PubMed ID: 25723713
[TBL] [Abstract][Full Text] [Related]
5. Extraglandular ocular involvement and morbidity and mortality in primary Sjögren's Syndrome.
Mathews PM; Robinson SA; Gire A; Baer AN; Akpek EK
PLoS One; 2020; 15(9):e0239769. PubMed ID: 32976549
[TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study of long-term outcomes in 152 patients with primary Sjogren's syndrome: 25-year experience.
Abrol E; González-Pulido C; Praena-Fernández JM; Isenberg DA
Clin Med (Lond); 2014 Apr; 14(2):157-64. PubMed ID: 24715127
[TBL] [Abstract][Full Text] [Related]
8. Assessment of patients with primary Sjögren's syndrome--outcome over 10 years using the Sjögren's Syndrome Damage Index.
Krylova L; Isenberg D
Rheumatology (Oxford); 2010 Aug; 49(8):1559-62. PubMed ID: 20444857
[TBL] [Abstract][Full Text] [Related]
9. [Lymphomas of the ocular adnexa in Gougerot-Sjögren syndrome. Apropos of 4 cases].
Chazerain P; Meyer O; Kaplan G; Brissaud P; Delmer A; Zufferey P; Kahn MF
Ann Med Interne (Paris); 1995; 146(4):223-5. PubMed ID: 7653938
[TBL] [Abstract][Full Text] [Related]
10. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
[TBL] [Abstract][Full Text] [Related]
11. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
Risselada AP; Kruize AA; Bijlsma JW
Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
[TBL] [Abstract][Full Text] [Related]
12. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
13. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects.
Baimpa E; Dahabreh IJ; Voulgarelis M; Moutsopoulos HM
Medicine (Baltimore); 2009 Sep; 88(5):284-293. PubMed ID: 19745687
[TBL] [Abstract][Full Text] [Related]
14. Long-term followup of patients with Sjögren's syndrome.
Kruize AA; Hené RJ; van der Heide A; Bodeutsch C; de Wilde PC; van Bijsterveld OP; de Jong J; Feltkamp TE; Kater L; Bijlsma JW
Arthritis Rheum; 1996 Feb; 39(2):297-303. PubMed ID: 8849383
[TBL] [Abstract][Full Text] [Related]
15. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome.
Ioannidis JP; Vassiliou VA; Moutsopoulos HM
Arthritis Rheum; 2002 Mar; 46(3):741-7. PubMed ID: 11920410
[TBL] [Abstract][Full Text] [Related]
16. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome.
Tzioufas AG; Boumba DS; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 1996 May; 39(5):767-72. PubMed ID: 8639173
[TBL] [Abstract][Full Text] [Related]
17. Lymphoma in Sjogren's syndrome.
Pavlidis NA; Drosos AA; Papadimitriou C; Talal N; Moutsopoulos HM
Med Pediatr Oncol; 1992; 20(4):279-83. PubMed ID: 1608349
[TBL] [Abstract][Full Text] [Related]
18. Probability of the development of non-Hodgkin's lymphoma in primary Sjögren's syndrome.
Hernández JA; Olivé A; Ribera JM; Tena X; Cuxart A; Feliu E
Scand J Rheumatol; 1996; 25(6):396-7. PubMed ID: 8996477
[No Abstract] [Full Text] [Related]
19. Ectopic Germinal Center-Like Structures in Minor Salivary Gland Biopsy Tissue Predict Lymphoma Occurrence in Patients With Primary Sjögren's Syndrome.
Sène D; Ismael S; Forien M; Charlotte F; Kaci R; Cacoub P; Diallo A; Dieudé P; Lioté F
Arthritis Rheumatol; 2018 Sep; 70(9):1481-1488. PubMed ID: 29669392
[TBL] [Abstract][Full Text] [Related]
20. Lymphomas in patients with Sjögren's syndrome: review of the literature and physiopathologic hypothesis.
Mariette X
Leuk Lymphoma; 1999 Mar; 33(1-2):93-9. PubMed ID: 10194125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
